A dose-titration and comparative study of rosuvastatin and atorvastatin in patients with homozygous familial hypercholesterolaemia

Atherosclerosis

Volumn 197, Issue 1, 2008, Pages 400-406

  Marais, A David ^a   Raal, Frederick J ^b   Stein, Evan A ^c   Rader, Daniel J ^d   Blasetto, James ^e   Palmer, Michael ^e   Wilpshaar, Wim ^e  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c Pharmaceutical Product Development   (United States)

^d HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^e ASTRAZENECA   (United Kingdom)

Author keywords

HMGCoA reductase inhibitors; Homozygous familial hypercholesterolaemia; Rosuvastatin

Indexed keywords

ALANINE AMINOTRANSFERASE; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ASPARTATE AMINOTRANSFERASE; ATORVASTATIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN; TRIACYLGLYCEROL; WARFARIN;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTHRALGIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACKACHE; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET THERAPY; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG DOSE TITRATION; DRUG EFFICACY; EPISTAXIS; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HEADACHE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; MULTICENTER STUDY; MYALGIA; NAUSEA; OPEN STUDY; PLASMAPHERESIS; PRIORITY JOURNAL; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

ADOLESCENT; ADULT; CHILD; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUOROBENZENES; HEPTANOIC ACIDS; HOMOZYGOTE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED; PYRIMIDINES; PYRROLES; SULFONAMIDES; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 39649084902     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.06.028     Document Type: Article

References (21)

1. Goldstein J.L., and Brown M.S. Familial hypercholesterolemia. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). Metabolic and molecular bases of inherited disease. 7th ed. (1995), McGraw-Hill, New York 1215-1250
2. Starzl T.E., Chase H.P., Ahrens Jr. E.H., et al. Portacaval shunt in patients with familial hypercholesterolemia. Ann Surg 198 (1983) 273-283
3. Marais A.D., Wood L., Firth J.C., Hall J.M., and Jacobs P. Plasma exchange for homozygous familial hypercholesterolaemia: the Cape Town experience. Transfus Sci 14 (1993) 239-247
4. Thompson G. Familial hypercholesterolemia. Lipoproteins Health Dis 38 (1999) 675-692
5. Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. The Hokuriku-FH-LDL-Apheresis Study Group. Am J Cardiol 1998;15:1489-95.
6. Marais A.D., Blom D.J., and Firth J.C. Statins in homozygous familial hypercholesterolemia. Curr Atheroscler Rep 4 (2002) 19-25
7. Moghadasian M.H., Frolich J.J., Saleem M., et al. Surgical management of dyslipidemia: clinical and experimental evidence. J Invest Surg 14 (2001) 71-78
8. Uauy R., Vega G.L., Grundy S.M., and Bilheimer D.M. Lovastatin therapy in receptor-negative homozygous familial hypercholesterolaemia: lack of effect on low-density lipoprotein concentrations or turnover. J Pediatr 113 (1988) 387-392
9. Thompson G.R., Ford J., Jenkinson M., and Trayner I. Efficacy of mevinolin as adjuvant therapy for refractory familial hypercholesterolaemia. Q J Med 60 (1986) 803-811
10. Raal F.J., Pilcher G.J., Illingworth D.R., et al. Expanded-dose simvastatin is effective in homozygous familial hypercholesterolaemia. Atherosclerosis 135 (1997) 249-256
11. Raal F.J., Pappu A.S., Illingworth D.R., et al. Inhibition of cholesterol synthesis by atorvastatin in homozygous familial hypercholesterolaemia. Atherosclerosis 150 (2000) 421-428
12. Marais A.D., Firth J.C., Naoumova R.P., and Thompson G.R. The role of HMG-C-A reductase inhibitors in homozygous familial hypercholesterolemia. In: Gotto A.M. (Ed). Drugs affecting lipid metabolism (1996), Kluwer Academic Publishers, New York 181-186
13. Marais A.D., Naoumova R.P., Firth J.C., et al. Decreased production of low density lipoprotein by atorvastatin after apheresis in homozygous familial hypercholesterolemia. J Lipid Res 38 (1997) 2071-2078
14. Olsson A.G., Pears J., McKellar J., Mizan J., and Raza A. Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia. Am J Cardiol 88 (2001) 504-508
15. Stein E., Strutt K.L., Miller E., and Southworth H. Efficacy and safety of rosuvastatin versus atorvastatin in patients with heterozygous familial hypercholesterolemia. Am J Cardiol 92 (2003) 1287-1293
16. Schneck D.W., Knopp R.H., Ballantyne C.M., et al. Comparative effects of rosuvastatin and atorvastatin across their dose ranges in patients with hypercholesterolemia and without active arterial disease. Am J Cardiol 91 (2003) 33-41
17. Jones P.H., Davidson M.H., Stein E.A., et al. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR trial). Am J Cardiol 92 (2003) 152-160
18. Remmell P.S., Gorder D.D., Hall Y., and Tillotson J.L. Assessing dietary adherence in the multiple risk factor intervention trial (MRFIT). I. Use of a dietary monitoring tool. J Am Diet Assoc 76 (1980) 351-356
19. Friedewald W.T., Levi R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
20. Gagne C., Gaudet D., Bruckert E., and The Ezetimibe Study Group. Efficacy and safety of ezetimibe co-administered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia. Circulation 105 (2002) 2469-2475
21. Abera A.B., Marais A.D., Raal F.J., et al. Autosomal recessive hypercholesterolaemia: discrimination of ARH protein and LDLR function in the homozygous FH phenotype. Clin Chim Acta 378 (2007) 33